Market Cap 1.10B
Revenue (ttm) 593.82M
Net Income (ttm) -55.76M
EPS (ttm) N/A
PE Ratio 52.07
Forward PE N/A
Profit Margin -9.39%
Debt to Equity Ratio 0.00
Volume 1,395,700
Avg Vol 1,208,080
Day's Range N/A - N/A
Shares Out 46.09M
Stochastic %K 68%
Beta 1.39
Analysts Sell
Price Target $26.20

Company Profile

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 888 229 3682
Address:
200 Summit Drive, 6th Floor, Burlington, United States
ApexEquityVault
ApexEquityVault May. 28 at 2:52 PM
$AZTA ADDED HEAVY!!
0 · Reply
Blockwave1
Blockwave1 May. 28 at 2:52 PM
$AZTA 🚨 18 JUN 26 $25 CALL $0.70 HUGE GAP ABOVE + SECTOR SENTIMENT + HIGH CONFIDENCE
0 · Reply
ApexEquityVault
ApexEquityVault May. 28 at 2:52 PM
$AZTA 18 JUN 26 $25 CALL $0.70 HUGE GAP ABOVE + SECTOR SENTIMENT + HIGH CONFIDENCE
0 · Reply
OnlyFibs
OnlyFibs May. 25 at 10:16 PM
$AZTA is attempting to build a floor and break its descending trendline after a catastrophic earnings gap-down on the back of slashed guidance and a massive impairment charge. 🌊 This is a high-risk structural reset for the life sciences giant. With the massive Q2 margin collapse fully priced in and the stock taking a historic haircut, bottom-fishers are actively positioning for a mean-reversion squeeze. However, management's lowered full-year outlook keeps the fundamental overhang incredibly heavy, leaving very little room for error on the immediate roadmap. 🎯 🐂 Bulls want to hold the 17.60 baseline to force a clean daily close over 20.39 targeting the heavy 22.67 supply shelf 🐻 Bears need to crack 17.60 to kill the dead-cat bounce and trigger a new wave of capitulation 📊 Lean NEUTRAL. #azta #trading #hovdid
0 · Reply
OnlyFibs
OnlyFibs May. 23 at 5:31 AM
$AZTA putting in a flat capitulation base right at the $18.50 demand floor after a heavy fiscal Q2 guidance reset 🌋 Life sciences play holds an absolute fortress balance sheet: $580M in pure cash and ZERO debt. Current market cap heavily discounts assets. ... 🐻 Bears need a break under $18.50 to test the deeper $15.00 cash floor. 📊 Lean neutral-to-BULLISH. Severe execution shortfalls are out, but the massive cash cushion de-risks the downside. Watch for the turn. #AZTA #hovdid
0 · Reply
OnlyFibs
OnlyFibs May. 21 at 2:29 AM
$AZTA down from $41 to $15.94 and now bouncing 5.15% off capitulation volume. Azenta life sciences automation — sample management, genomic services, biobanking. Volume exhaustion at the lows confirmed the bottom. ITM $17.5 call sweep just hit with spot at $17.86. RSI launching from near 20. Someone decided the floor is in. 🐂 $18.57 holds and $19.60 then $22 then $24.24 happen in sequence. Capitulation volume + ITM call sweep + RSI recovery = three reasons to pay attention. 🐻 $17.60 loses and the bounce was just relief. $16.94 then $15.94 retest. Life sciences spending still under pressure. ⚠️ ITM call sweep same day as the capitulation volume bounce. That's not random timing. Bottom volume printed. Sweep confirmed. Recovery has a case. #AZTA #Azenta #LifeSciences #OptionsFlow #TechnicalAnalysis #hovdid
0 · Reply
OnlyFibs
OnlyFibs May. 20 at 2:34 AM
$AZTA — Azenta. Life sciences automation, biobanking, genomics services. Has spent 4 years in one of the most brutal downtrends on any chart — $90 to $7.94. Multi-decade low hit. Gap from 2016 finally filled. Volume exhaustion on the capitulation wick. And today it's up 8.68%. 🐂 Gap fill + volume exhaustion at decade lows = capitulation bottom thesis. $19 reclaim → $25–29. Activist or strategic catalyst = violent squeeze. 🐻 Every rally in this downtrend has been sold. Pink trendline from 2021 is still miles above. Life sciences spending still under pressure. ⚠️ $7.94 decade low + gap fill + 8.68% bounce today. Either the bottom is in or this is a dead cat. Volume on the flush suggests real capitulation. #AZTA #Azenta #LifeSciences #Biotech #TechnicalAnalysis #hovdid
0 · Reply
topstockalerts
topstockalerts May. 20 at 1:11 AM
$AZTA the market is rewarding anyone who stayed patient.
0 · Reply
FilingTracker
FilingTracker May. 19 at 8:16 PM
$AZTA Insider purchase: https://www.sec.gov/Archives/edgar/data/933974/000119312526230764/xslF345X06/ownership.xml
0 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 12:26 PM
$AZTA Current Stock Price: $19.22 Contracts to trade: $20.0 AZTA May 15 2026 Call Entry: $1.01 Exit: $1.39 ROI: 38% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Latest News on AZTA
Azenta Earnings Call Transcript: Q2 2026

May 6, 2026, 8:30 AM EDT - 4 weeks ago

Azenta Earnings Call Transcript: Q2 2026


Azenta Earnings release: Q2 2026

May 6, 2026, 8:30 AM EDT - 4 weeks ago

Azenta Earnings release: Q2 2026


Azenta Slides: Q2 2026

May 6, 2026, 8:30 AM EDT - 4 weeks ago

Azenta Slides: Q2 2026


Azenta Quarterly report: Q2 2026

May 6, 2026, 8:30 AM EDT - 4 weeks ago

Azenta Quarterly report: Q2 2026


Azenta price target lowered to $35 from $45 at Evercore ISI

2026-04-06T12:08:13.000Z - 2 months ago

Azenta price target lowered to $35 from $45 at Evercore ISI


Azenta price target lowered to $35 from $40 at Jefferies

2026-04-01T18:00:18.000Z - 2 months ago

Azenta price target lowered to $35 from $40 at Jefferies


Azenta Transcript: M&A announcement

Mar 10, 2026, 10:00 AM EDT - 3 months ago

Azenta Transcript: M&A announcement


Azenta Press release: M&A announcement

Mar 10, 2026, 10:00 AM EDT - 3 months ago

Azenta Press release: M&A announcement


Azenta Slides: M&A announcement

Mar 10, 2026, 10:00 AM EDT - 3 months ago

Azenta Slides: M&A announcement


Azenta, Frontier Space announce strategic partnership

2026-02-09T21:16:38.000Z - 4 months ago

Azenta, Frontier Space announce strategic partnership


Azenta price target lowered to $45 from $50 at Evercore ISI

2026-02-05T13:15:20.000Z - 4 months ago

Azenta price target lowered to $45 from $50 at Evercore ISI


Azenta price target lowered to $30 from $39 at TD Cowen

2026-02-04T19:10:26.000Z - 4 months ago

Azenta price target lowered to $30 from $39 at TD Cowen


Azenta Earnings Call Transcript: Q1 2026

Feb 4, 2026, 8:30 AM EST - 4 months ago

Azenta Earnings Call Transcript: Q1 2026


Azenta Quarterly report: Q1 2026

Feb 4, 2026, 8:30 AM EST - 4 months ago

Azenta Quarterly report: Q1 2026


Azenta Earnings release: Q1 2026

Feb 4, 2026, 8:30 AM EST - 4 months ago

Azenta Earnings release: Q1 2026


Azenta Slides: Q1 2026

Feb 4, 2026, 8:30 AM EST - 4 months ago

Azenta Slides: Q1 2026


Azenta reports Q1 EPS 9c, consensus 13c

2026-02-04T12:00:54.000Z - 4 months ago

Azenta reports Q1 EPS 9c, consensus 13c


Azenta backs FY26 organic revenue view 3%-5%

2026-02-04T12:00:32.000Z - 4 months ago

Azenta backs FY26 organic revenue view 3%-5%


Azenta Transcript: AGM 2026

Jan 28, 2026, 9:00 AM EST - 4 months ago

Azenta Transcript: AGM 2026


Azenta price target raised to $39 from $35 at TD Cowen

2026-01-08T14:43:17.000Z - 5 months ago

Azenta price target raised to $39 from $35 at TD Cowen


Azenta price target raised to $39 from $35 at TD Cowen

2026-01-08T14:35:24.000Z - 5 months ago

Azenta price target raised to $39 from $35 at TD Cowen


Azenta upgraded to Outperform from In Line at Evercore ISI

2026-01-05T11:20:32.000Z - 5 months ago

Azenta upgraded to Outperform from In Line at Evercore ISI


Azenta price target raised to $44 from $42 at Needham

2025-12-19T12:51:17.000Z - 5 months ago

Azenta price target raised to $44 from $42 at Needham


Azenta Proxy statement: Proxy Filing

Dec 19, 2025, 7:00 AM EST - 5 months ago

Azenta Proxy statement: Proxy Filing


Azenta Proxy statement: Proxy Filing

Dec 18, 2025, 7:00 AM EST - 6 months ago

Azenta Proxy statement: Proxy Filing


Azenta Proxy statement: Proxy Filing

Dec 18, 2025, 7:00 AM EST - 6 months ago

Azenta Proxy statement: Proxy Filing


Azenta authorizes $250M share repurchase program

2025-12-10T17:45:14.000Z - 6 months ago

Azenta authorizes $250M share repurchase program


Azenta Transcript: Investor Day 2025

Dec 10, 2025, 12:45 PM EST - 6 months ago

Azenta Transcript: Investor Day 2025


Azenta Slides: FY 2025

Dec 10, 2025, 12:45 PM EST - 6 months ago

Azenta Slides: FY 2025


Azenta Authorizes $250 Million Share Repurchase Program

Dec 10, 2025, 12:43 PM EST - 6 months ago

Azenta Authorizes $250 Million Share Repurchase Program


Azenta to host investor day

2025-12-10T15:45:20.000Z - 6 months ago

Azenta to host investor day


Azenta price target raised to $45 from $35 at Raymond James

2025-11-25T16:35:20.000Z - 6 months ago

Azenta price target raised to $45 from $35 at Raymond James


Azenta upgraded to Hold from Sell at Nephron Research

2025-11-24T12:25:09.000Z - 6 months ago

Azenta upgraded to Hold from Sell at Nephron Research


Azenta Earnings Call Transcript: Q4 2025

Nov 21, 2025, 8:30 AM EST - 6 months ago

Azenta Earnings Call Transcript: Q4 2025


Azenta Annual report: Q4 2025

Nov 21, 2025, 8:30 AM EST - 6 months ago

Azenta Annual report: Q4 2025


Azenta Earnings release: Q4 2025

Nov 21, 2025, 8:30 AM EST - 6 months ago

Azenta Earnings release: Q4 2025


Azenta Slides: Q4 2025

Nov 21, 2025, 8:30 AM EST - 6 months ago

Azenta Slides: Q4 2025


Azenta Earnings Call Transcript: Q3 2025

Aug 5, 2025, 8:30 AM EDT - 10 months ago

Azenta Earnings Call Transcript: Q3 2025


Azenta Quarterly report: Q3 2025

Aug 5, 2025, 8:30 AM EDT - 10 months ago

Azenta Quarterly report: Q3 2025


Azenta Earnings release: Q3 2025

Aug 5, 2025, 8:30 AM EDT - 10 months ago

Azenta Earnings release: Q3 2025


Azenta Slides: Q3 2025

Aug 5, 2025, 8:30 AM EDT - 10 months ago

Azenta Slides: Q3 2025


Azenta Earnings Call Transcript: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Azenta Earnings Call Transcript: Q2 2025


Azenta Quarterly report: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Azenta Quarterly report: Q2 2025


Azenta Earnings release: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Azenta Earnings release: Q2 2025


Azenta Slides: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Azenta Slides: Q2 2025


Azenta Transcript: KeyBanc Annual Healthcare Forum 2025

Mar 19, 2025, 10:30 AM EDT - 1 year ago

Azenta Transcript: KeyBanc Annual Healthcare Forum 2025


Azenta Earnings Call Transcript: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Azenta Earnings Call Transcript: Q1 2025


Azenta Quarterly report: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Azenta Quarterly report: Q1 2025


Azenta Earnings release: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Azenta Earnings release: Q1 2025


Azenta Slides: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Azenta Slides: Q1 2025


Azenta Proxy statement: Proxy Filing

Dec 17, 2024, 7:00 AM EST - 1 year ago

Azenta Proxy statement: Proxy Filing


Azenta Proxy statement: Proxy Filing

Dec 17, 2024, 7:00 AM EST - 1 year ago

Azenta Proxy statement: Proxy Filing


Final Trade: BABA, GOOGL, AZTA, GDX

Nov 22, 2024, 6:35 PM EST - 1 year ago

Final Trade: BABA, GOOGL, AZTA, GDX

GDX GOOG GOOGL BABA


Azenta Earnings Call Transcript: Q4 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Azenta Earnings Call Transcript: Q4 2024


Azenta Annual report: Q4 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Azenta Annual report: Q4 2024


Azenta Earnings release: Q4 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Azenta Earnings release: Q4 2024


Azenta Slides: Q4 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Azenta Slides: Q4 2024


ApexEquityVault
ApexEquityVault May. 28 at 2:52 PM
$AZTA ADDED HEAVY!!
0 · Reply
Blockwave1
Blockwave1 May. 28 at 2:52 PM
$AZTA 🚨 18 JUN 26 $25 CALL $0.70 HUGE GAP ABOVE + SECTOR SENTIMENT + HIGH CONFIDENCE
0 · Reply
ApexEquityVault
ApexEquityVault May. 28 at 2:52 PM
$AZTA 18 JUN 26 $25 CALL $0.70 HUGE GAP ABOVE + SECTOR SENTIMENT + HIGH CONFIDENCE
0 · Reply
OnlyFibs
OnlyFibs May. 25 at 10:16 PM
$AZTA is attempting to build a floor and break its descending trendline after a catastrophic earnings gap-down on the back of slashed guidance and a massive impairment charge. 🌊 This is a high-risk structural reset for the life sciences giant. With the massive Q2 margin collapse fully priced in and the stock taking a historic haircut, bottom-fishers are actively positioning for a mean-reversion squeeze. However, management's lowered full-year outlook keeps the fundamental overhang incredibly heavy, leaving very little room for error on the immediate roadmap. 🎯 🐂 Bulls want to hold the 17.60 baseline to force a clean daily close over 20.39 targeting the heavy 22.67 supply shelf 🐻 Bears need to crack 17.60 to kill the dead-cat bounce and trigger a new wave of capitulation 📊 Lean NEUTRAL. #azta #trading #hovdid
0 · Reply
OnlyFibs
OnlyFibs May. 23 at 5:31 AM
$AZTA putting in a flat capitulation base right at the $18.50 demand floor after a heavy fiscal Q2 guidance reset 🌋 Life sciences play holds an absolute fortress balance sheet: $580M in pure cash and ZERO debt. Current market cap heavily discounts assets. ... 🐻 Bears need a break under $18.50 to test the deeper $15.00 cash floor. 📊 Lean neutral-to-BULLISH. Severe execution shortfalls are out, but the massive cash cushion de-risks the downside. Watch for the turn. #AZTA #hovdid
0 · Reply
OnlyFibs
OnlyFibs May. 21 at 2:29 AM
$AZTA down from $41 to $15.94 and now bouncing 5.15% off capitulation volume. Azenta life sciences automation — sample management, genomic services, biobanking. Volume exhaustion at the lows confirmed the bottom. ITM $17.5 call sweep just hit with spot at $17.86. RSI launching from near 20. Someone decided the floor is in. 🐂 $18.57 holds and $19.60 then $22 then $24.24 happen in sequence. Capitulation volume + ITM call sweep + RSI recovery = three reasons to pay attention. 🐻 $17.60 loses and the bounce was just relief. $16.94 then $15.94 retest. Life sciences spending still under pressure. ⚠️ ITM call sweep same day as the capitulation volume bounce. That's not random timing. Bottom volume printed. Sweep confirmed. Recovery has a case. #AZTA #Azenta #LifeSciences #OptionsFlow #TechnicalAnalysis #hovdid
0 · Reply
OnlyFibs
OnlyFibs May. 20 at 2:34 AM
$AZTA — Azenta. Life sciences automation, biobanking, genomics services. Has spent 4 years in one of the most brutal downtrends on any chart — $90 to $7.94. Multi-decade low hit. Gap from 2016 finally filled. Volume exhaustion on the capitulation wick. And today it's up 8.68%. 🐂 Gap fill + volume exhaustion at decade lows = capitulation bottom thesis. $19 reclaim → $25–29. Activist or strategic catalyst = violent squeeze. 🐻 Every rally in this downtrend has been sold. Pink trendline from 2021 is still miles above. Life sciences spending still under pressure. ⚠️ $7.94 decade low + gap fill + 8.68% bounce today. Either the bottom is in or this is a dead cat. Volume on the flush suggests real capitulation. #AZTA #Azenta #LifeSciences #Biotech #TechnicalAnalysis #hovdid
0 · Reply
topstockalerts
topstockalerts May. 20 at 1:11 AM
$AZTA the market is rewarding anyone who stayed patient.
0 · Reply
FilingTracker
FilingTracker May. 19 at 8:16 PM
$AZTA Insider purchase: https://www.sec.gov/Archives/edgar/data/933974/000119312526230764/xslF345X06/ownership.xml
0 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 12:26 PM
$AZTA Current Stock Price: $19.22 Contracts to trade: $20.0 AZTA May 15 2026 Call Entry: $1.01 Exit: $1.39 ROI: 38% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
NEWBTrader96
NEWBTrader96 May. 6 at 1:23 PM
$AZTA loading up 12 shares after the crash following bad earnings.
0 · Reply
Estimize
Estimize May. 6 at 12:39 AM
$AZTA reported -0.04 EPS and 144.80 revenue for Q2. http://www.estimize.com/intro/azta?chart=historical&metric_name=eps&utm_content=AZTA&ut
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 5 at 8:55 PM
$AZTA Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$3.49 down -772.50% YoY • Reported revenue of $144.79M up 0.96% YoY • Azenta expects FY'26 total reported revenue from continuing operations to be $603M-$621M. Organic revenue is now projected down 2% to up 1%, a reduction from prior guidance, and Adjusted EBITDA margin is expected down 125 bps to flat.
0 · Reply
BillionerOfKing
BillionerOfKing May. 4 at 9:01 PM
$AZTA Current Stock Price: $24.32 Contracts to trade: $25.0 AZTA May 15 2026 Call Entry: $0.05 Exit: $0.09 ROI: 86% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JackDarwin
JackDarwin Apr. 15 at 10:27 AM
$AZTA Three Outside Up Candlestick Pattern Formed with Good Volume
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 31 at 11:26 AM
$AZTA Share Price: $20.26 Contract Selected: Oct 16, 2026 $25 Calls Buy Zone: $1.91 – $2.36 Target Zone: $3.49 – $4.27 Potential Upside: 73% ROI Time to Expiration: 198 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
PenkeInvesting
PenkeInvesting Mar. 13 at 2:19 PM
Fundamental analysis of $AZTA (Azenta, Inc.) based on financial data and reported results. #AZTA
0 · Reply
The_Trading_Mechanic
The_Trading_Mechanic Mar. 9 at 9:15 PM
Azenta is currently trading near major long-term support, sitting at historical lows that have acted as an important demand zone for the company. The stock has recently tagged and defended its $1 billion market cap level, which is often a psychologically and institutionally significant valuation floor. When a company successfully holds that level, it can signal stabilization and early accumulation. If AZTA is going to bounce, this is the area where momentum should begin building. A decisive breakout above the $32.00 level would confirm renewed bullish strength and open the path toward the $47.31 resistance, representing meaningful upside from current levels. With a clearly defined stop loss at $18.63, this setup presents a compelling risk-to-reward ratio, allowing for controlled downside while targeting a strong recovery move. If you enjoy my analysis and want to see more trade ideas like this, your support means the world to me! Consider liking, sharing, or following for more deep dives into market opportunities.
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 18 at 10:52 AM
$AZTA Share Price: $28.64 Contract Selected: Jul 17, 2026 $30 Calls Buy Zone: $6.03 – $7.46 Target Zone: $9.74 – $11.91 Potential Upside: 52% ROI Time to Expiration: 148 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
PointFigureIQ
PointFigureIQ Feb. 4 at 1:44 PM
$AZTA is a life sciences tools company providing high-purity materials and services; its performance is correlated with biopharma R&D spending, which has softened.
0 · Reply